Cargando…
Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography
Immuno-oncological treatment strategies that target abnormal receptor profiles of tumors are an increasingly important feature of cancer therapy. Yet, assessing receptor availability (RA) and drug-target engagement, important determinants of therapeutic efficacy, is challenging with current imaging...
Autores principales: | Meng, Boyu, Folaron, Margaret R., Strawbridge, Rendall R., Sadeghipour, Negar, Samkoe, Kimberley S., Tichauer, Kenneth, Davis, Scott C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532673/ https://www.ncbi.nlm.nih.gov/pubmed/33042280 http://dx.doi.org/10.7150/thno.45273 |
Ejemplares similares
-
Examining the Feasibility of Quantifying Receptor Availability Using Cross-Modality Paired-Agent Imaging
por: Meng, Boyu, et al.
Publicado: (2021) -
Prediction of optimal contrast times post-imaging agent administration to inform personalized fluorescence-guided surgery
por: Sadeghipour, Negar, et al.
Publicado: (2020) -
Topical dual-probe staining using quantum dot-labeled antibodies for identifying tumor biomarkers in fresh specimens
por: Meng, Boyu, et al.
Publicado: (2020) -
Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols
por: Wang, Cheng, et al.
Publicado: (2021) -
Characterizing short-wave infrared fluorescence of conventional near-infrared fluorophores
por: Byrd, Brook K., et al.
Publicado: (2019)